Do Steroid Injections Help Bulging Discs?

Epidural steroid injections do help most people with bulging discs, though the benefit is strongest in the first few weeks and tends to fade over time. Research comparing outcomes in patients with disc bulging versus disc protrusion found that both groups experienced meaningful drops in pain and disability scores after injection, with improvements holding at six months. The picture gets more interesting when you dig into how much relief, for how long, and for whom, because the honest answer is not simply “yes” or “no” but something more conditional.

What the Research Shows for Bulging Discs Specifically

Most studies on epidural steroid injections lump all types of disc problems together, so data that isolates bulging discs (where the disc expands outward but doesn’t rupture through its outer layer) from true herniations or protrusions is valuable. One study that did make this distinction found that patients with both bulging discs and disc protrusions benefited from epidural steroid injection. Pain scores and disability scores dropped significantly at one week, one month, and six months after the procedure in both groups. However, after the first week, patients with disc protrusions tended to get more relief than those with simple bulges.¹

This makes intuitive sense. A protrusion presses more directly on a nerve root, and the inflammation around that compressed nerve is exactly what the steroid is targeting. A bulging disc may cause pain through a broader, less focal mechanism, so the concentrated anti-inflammatory punch of an epidural injection has a slightly less dramatic effect. That said, “slightly less dramatic” still means real, measurable improvement for many patients. The evidence also suggests that epidural steroids tend to work better for disc-related problems than for spinal canal narrowing unrelated to a disc.²

How Quickly Relief Happens and How Long It Lasts

One of the most useful findings from recent research is that how you feel within the first few hours after an injection strongly predicts how you will feel a month later. In lumbar injections, patients who experienced more than a 50 percent drop in pain within four hours were roughly three and a half times more likely to still be responders a month out than those who did not get that early relief.³ A similar pattern was found in cervical injections, where early responders were about four times as likely to remain improved at one month.⁴ If you walk out of the procedure room and feel substantially better within a few hours, that is a genuinely encouraging sign.

The harder question is what happens over months and years. A large evidence synthesis covering 72 randomized controlled trials and over 7,700 patients concluded that epidural steroid injections beat other conservative treatments for sciatica-type leg pain, but do not provide lasting long-term results.⁵ That framing can sound discouraging, but it deserves some context. One longer-term follow-up study tracked patients for two years after a single transforaminal injection and found that about 54 percent were still responding well at the 24-month mark. The patients who eventually lost the benefit tended to drop off over the first one to six months, not suddenly at some cliff.⁶ So while the injection is not a permanent fix for most people, a meaningful fraction carry that benefit for a long time.

How Injections Compare to Oral Steroids

A common question is whether you can just take steroid pills instead of getting a needle in your spine. A prospective study comparing transforaminal epidural injections with a course of oral steroids for acute lumbar radiculopathy found that injections delivered substantially faster and greater relief. Within the first few weeks, the injection group saw roughly 70 percent reductions in leg pain and 60 percent reductions in back pain, with much better functional improvement than the oral steroid group.⁷

Here is the catch: by about 12 weeks, the gap between the two groups shrank and was no longer statistically significant. Both groups ended up in roughly the same place. This tells you something important about the role of injections. They are not doing something fundamentally different from what a steroid pill does; they are delivering the drug directly to the inflamed tissue, which produces a faster and more powerful early response. If you can tolerate a slower recovery and your pain is manageable in the interim, oral steroids may eventually get you to a similar outcome. But if your pain is severe enough that those early weeks matter a great deal to your quality of life or your ability to function, the injection route offers a clear short-term advantage.

The Placebo Problem Is More Complicated Than You Think

Critics of epidural steroid injections sometimes point to trials showing that saline injections into the epidural space also reduce pain. If salt water works too, the argument goes, maybe the steroid itself is not doing much. But a systematic review and meta-analysis that examined this question closely concluded that epidural saline is not a true placebo at all. It has its own therapeutic effect, likely because injecting any fluid into the epidural space physically displaces inflamed tissue, dilutes inflammatory chemicals, and may disrupt pain signaling. Both saline and steroid injections into the epidural space performed beyond what a real placebo would achieve, reducing pain scores by about 20 percent.⁸

This actually means many trials underestimate the real benefit of epidural injections, because they compare steroid injections against an “active control” rather than against no treatment. When both arms of a trial show improvement, the difference between them can look small even though both groups are doing considerably better than they would have untreated. The evidence synthesis of 72 trials noted above, which compared injections to other conservative approaches rather than to epidural saline, found a clearer advantage for the steroid group.

Transforaminal Versus Interlaminar Approaches

There are different ways to get the steroid to the epidural space. The two most common for lumbar disc problems are the transforaminal route, which threads the needle alongside the nerve root where it exits the spine, and the interlaminar route, which goes through the gap between vertebral arches. There is a persistent debate about which is better.

One registry study found that patients receiving transforaminal injections had roughly three times the odds of achieving at least a 50 percent drop in leg pain compared to those receiving interlaminar injections.⁹ But another study comparing the two approaches head-to-head found no significant difference in pain scores or functional outcomes at one, three, or six months.¹⁰ The conflicting results are common in this field. In practice, many physicians choose the transforaminal route when there is a clear single nerve root being compressed, because it delivers the steroid closest to the problem. The interlaminar approach may be preferred when the pain pattern is more diffuse or when the anatomy makes transforaminal access difficult.

Regardless of the approach, image guidance matters. Early research established that “blind” injections without fluoroscopy or other imaging frequently miss the intended target, and the current standard calls for real-time imaging to verify accurate needle placement before the steroid is injected.¹¹ If you are offered an injection without any imaging guidance, that is worth questioning.

Where the Disc Bulge Is Located

The location of a disc abnormality in relation to the spinal canal adds another layer of variability. A comprehensive review of disc features that predict response to injection found that the relationship between herniation location and outcomes is messy. Some studies found foraminal or extraforaminal herniations responded better, possibly because the injection can more easily reach the affected nerve. Other research found that paramedian herniations did better. At least one study found no meaningful difference based on location at all.¹² The takeaway is that location alone does not predict whether an injection will work for you. It interacts with how much the nerve is actually being compressed and how accessible that nerve is to the needle.

Can Injections Prevent Surgery?

One of the hopes people have when getting an epidural steroid injection is that it will buy enough time for the disc to heal on its own, avoiding surgery altogether. A meta-analysis of randomized controlled trials found that the surgery-sparing effect exists but is modest and short-lived. In the first year, patients who received injections were somewhat less likely to go on to surgery compared to those who received other conservative treatments. Beyond a year, that difference faded.¹³ For some patients, that year of delay is enormously valuable because disc herniations can shrink naturally over time. But going in expecting the injection to permanently eliminate the possibility of surgery would be unrealistic.

Risks and Side Effects Worth Knowing About

Serious complications from epidural steroid injections are rare. In 2014, the FDA issued a warning acknowledging that injection of corticosteroids into the epidural space could, in rare cases, lead to severe neurological events. A subsequent expert consortium concluded that such complications were genuinely uncommon and recommended procedural safeguards, including contrast injection to verify needle placement, that further reduce the risk.¹⁴

The more common and underappreciated side effect is a temporary spike in blood sugar, which is clinically significant for people with diabetes. One study found that diabetic patients experienced an average blood glucose increase of about 126 points the day after an injection, with levels returning to baseline within roughly two days.¹⁵ Another study found that blood glucose rose significantly the day after injection but normalized by day two, with patients whose diabetes was less well controlled experiencing bigger spikes.¹⁶ Research comparing a higher steroid dose (40 mg) to a lower one (20 mg) found that the higher dose caused larger and more prolonged blood sugar elevations, with fasting glucose remaining elevated for three days versus just one day at the lower dose.¹⁷ If you have diabetes, your doctor should be discussing this with you and potentially adjusting your insulin regimen around the procedure.

The choice between particulate and non-particulate steroid formulations also comes up in safety discussions. Particulate steroids have been linked to rare cases of post-procedure paralysis, possibly from particles blocking blood flow to the spinal cord. A systematic review comparing the two types found no significant difference in pain reduction, meaning non-particulate formulations achieve similar results without the added embolic risk.¹⁸ Many practitioners now prefer non-particulate steroids, especially for transforaminal injections where the needle is closer to critical blood vessels.

Why What You Do After the Injection Matters

An epidural steroid injection is often most useful not as a standalone treatment but as a window of reduced pain that lets you do something more active. A randomized trial tested what happens when patients with lumbar disc herniation add structured exercise to their post-injection routine. Patients who did either aerobic exercise or core-stabilization training after a caudal epidural injection achieved greater pain relief and functional improvement than those who received only standard physiotherapy. Core-stabilization exercises produced faster initial pain reduction, though both exercise approaches performed equally well by the 12-week mark.¹⁹

This fits a broader pattern in spine care: injections reduce inflammation and pain enough that you can move, and the movement itself contributes to longer-term recovery by strengthening the muscles that support your spine and reducing the mechanical stress on the disc. Treating the injection as a complete solution, rather than an opportunity to rehabilitate, probably explains some of the disappointing long-term numbers in larger studies.

The Role of Depression and Anxiety

Psychological factors influence injection outcomes more than most patients realize. A prospective study measuring depression and anxiety levels before injection found that higher pre-treatment depression scores correlated with less pain reduction at both three weeks and three months after the procedure.²⁰ Pre-treatment anxiety and a tendency to focus on physical sensations were also linked to higher baseline disability, though they did not directly predict whether the injection succeeded or failed.

This does not mean the pain is “in your head.” It means that chronic pain and mood disorders share overlapping neural pathways, and when the brain’s pain-processing system is already amplified by depression, a local anti-inflammatory intervention has a harder time turning the volume down. If you have been struggling with mood alongside your back pain, addressing both gives the injection its best shot at working.

Cost-Effectiveness

An economic evaluation alongside a randomized trial in general practice found that epidural steroid injections for acute radiculopathy were cost-effective compared to usual care. Total costs were actually lower in the injection group, largely because patients returned to work sooner. Without any additional investment, the probability that injections were the more cost-effective option was over 80 percent.²¹ The faster return to function, even if the long-term pain outcomes eventually converge with other conservative approaches, carries real economic value that does not always get factored into clinical discussions about whether injections are “worth it.”

Platelet-Rich Plasma as an Emerging Alternative

Research is beginning to compare epidural steroids with biologic alternatives like platelet-rich plasma. A prospective study of 60 patients with degenerative disc disease randomized to receive either steroid or PRP injections directly into the disc found that steroids provided greater pain relief at two months, but PRP produced significantly better results at six months.²² The logic is that PRP contains growth factors that may promote tissue repair rather than simply suppressing inflammation. This is still early-stage evidence from a single relatively small trial, and intradiscal PRP injection is a different procedure from an epidural steroid injection. But the pattern of steroids winning the short game while a biologic approach performs better over months is exactly the kind of tradeoff that will shape future treatment decisions if larger trials confirm it.